Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Qsymia published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-6 of 6
» View wsbt.com items only
    May 24, 2013 |Story| Reuters

  1. Novo obesity drug could launch in U.S. end 2014

    Reuters
    COPENHAGEN (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential. The world's biggest insulin...

    Tags: Vivus Inc., Arena Pharmaceuticals, Inc., Weight, Belviq, Deutsche Bank AG

    2. May 23, 2013 |Story| Reuters

  2. Denner added as nominee to Vivus board by activist investor

    Reuters
    By Bill Berkrot May 23 (Reuters) - First Manhattan Company (FMC) added some heavyweight muscle on Thursday to its bid to shake up the board of drugmaker Vivus Inc by naming former Carl Icahn top lieutenant Alex Denner and two others to its slate of...

    Tags: Vivus Inc., Board of Directors, ImClone Systems Incorporated, Lilly Eli & Co, Economy, Business and Finance

    3. Dec 5, 2012 |Story| Chicago Tribune

  3. Weigh pros and cons of 2 new diet drugs

    Weight-loss drugs have so far been a complete bust. But they may be verging on a comeback, now that the Food and Drug Administration has approved two new prescription diet pills for the first time in more than a decade.
    Weight-loss drugs have so far been a complete bust. But they may be verging on a comeback, now that the Food and Drug Administration has approved two new prescription diet pills for the first time in more than a decade. Both weight-loss medications...

    Tags: Mouth, High Blood Pressure, George Washington University, Physical Conditions, Food and Drug Administration

    4. Jul 17, 2012 |Story| CNN
  4. |Story

    Tags: Vivus Inc., Family Planning, High Blood Pressure, Marketing, Food and Drug Administration

    5. Jun 27, 2012 |Story| Los Angeles Times

  5. FDA approves lorcaserin, first weight-loss drug since 1999

    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999.
    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999. Once it is cleared by the Drug Enforcement...

    Tags: High Blood Pressure, Food and Drug Administration, Diabetes, Phentermine (drug), High Cholesterol

    6. Mar 29, 2012 |Story| Reuters

  6. Obesity drugs need heart studies, U.S. advisers say

    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval.
    Reuters
    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval. An advisory panel to the U.S. Food and Drug Administration...

    Tags: Vivus Inc., High Blood Pressure, Economy, Business and Finance, Drug Trafficking, Stock Market

Original site for Qsymia topic gallery.